|Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis|
JP Baillargeon, DK McClish, PA Essah, JE Nestler
The Journal of Clinical Endocrinology & Metabolism 90 (7), 3863-3870, 2005
|Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity|
JP Baillargeon, DJ Jakubowicz, MJ Iuorno, S Jakubowicz, JE Nestler
Fertility and sterility 82 (4), 893-902, 2004
|Insulin and hyperandrogenism in women with polycystic ovary syndrome|
CG Baptiste, MC Battista, A Trottier, JP Baillargeon
The Journal of steroid biochemistry and molecular biology 122 (1-3), 42-52, 2010
|A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills|
E Diamanti-Kandarakis, JP Baillargeon, MJ Iuorno, DJ Jakubowicz, ...
J Clin Endocrinol Metab 88 (5), 1927-1932, 2003
|Polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?|
JP Baillargeon, JE Nestler
The Journal of Clinical Endocrinology & Metabolism 91 (1), 22-24, 2006
|Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases|
SM Ruchat, AA Houde, G Voisin, J St-Pierre, P Perron, JP Baillargeon, ...
Epigenetics 8 (9), 935-943, 2013
|Basic infertility including polycystic ovary syndrome|
M Brassard, Y AinMelk, JP Baillargeon
Medical Clinics of North America 92 (5), 1163-1192, 2008
|Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome|
MJ Iuorno, DJ Jakubowicz, JP Baillargeon, P Dillon, RD Gunn, G Allan, ...
Endocrine Practice 8 (6), 417-423, 2002
|Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction|
E Papaleo, V Unfer, JP Baillargeon, L De Santis, F Fusi, C Brigante, ...
Gynecological Endocrinology 23 (12), 700-703, 2007
|Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome|
JP Baillargeon, E Diamanti-Kandarakis, RE Ostlund, T Apridonidze, ...
Diabetes care 29 (2), 300-305, 2006
|Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial|
E Papaleo, V Unfer, JP Baillargeon, F Fusi, F Occhi, L De Santis
Fertility and sterility 91 (5), 1750-1754, 2009
|Insulin sensitizers for polycystic ovary syndrome|
JP Baillargeon, MJ Iuorno, JE Nestler
Clinical obstetrics and gynecology 46 (2), 325-340, 2003
|Reproducibility of the 6-minute walk test in obese adults|
K Beriault, AC Carpentier, C Gagnon, J Ménard, JP Baillargeon, ...
International journal of sports medicine 30 (10), 725-727, 2009
|Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy|
DJ Jakubowicz, PA Essah, M Seppälä, S Jakubowicz, JP Baillargeon, ...
The Journal of Clinical Endocrinology & Metabolism 89 (2), 833-839, 2004
|Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity|
C Roberge, AC Carpentier, MF Langlois, JP Baillargeon, JL Ardilouze, ...
American Journal of Physiology-Endocrinology and Metabolism 293 (6), E1465-E1478, 2007
|Insulin-stimulated release of D-chiro-inositol–containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome|
KI Cheang, JP Baillargeon, PA Essah, RE Ostlund Jr, T Apridonize, ...
Metabolism 57 (10), 1390-1397, 2008
|Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity|
JP Baillargeon, A Carpentier
Fertility and sterility 88 (4), 886-893, 2007
|Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: a systematic review and meta-analysis|
A Baillot, AJ Romain, K Boisvert-Vigneault, M Audet, JP Baillargeon, ...
PLoS One 10 (4), e0119017, 2015
|Use of insulin sensitizers in polycystic ovarian syndrome.|
Current opinion in investigational drugs (London, England: 2000) 6 (10 …, 2005
|Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism|
JP Baillargeon, JE Nestler, RE Ostlund, T Apridonidze, ...
Human Reproduction 23 (6), 1439-1446, 2008